![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Malawska Barbara Kulig Katarzyna
Publisher: Informa Healthcare
ISSN: 1354-3784
Source: Expert Opinion on Investigational Drugs, Vol.17, Iss.3, 2008-03, pp. : 361-369
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Brivaracetam for the treatment of epilepsy
Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 12, 2011-08 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
New targets for neuropathic pain therapeutics
Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 4, 2005-08 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Pexton Terry Moeller-Bertram Tobias Schilling Jan M Wallace Mark S
Expert Opinion on Investigational Drugs, Vol. 20, Iss. 9, 2011-09 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
NMDA receptors as targets for drug action in neuropathic pain
By Parsons C.G.
European Journal of Pharmacology, Vol. 429, Iss. 1, 2001-10 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Neuropathic Pain: Some Clues for Future Drug Treatments
Mini Reviews in Medicinal Chemistry, Vol. 3, Iss. 7, 2003-11 ,pp. :